<DOC>
	<DOCNO>NCT00755326</DOCNO>
	<brief_summary>The purpose study determine traditional Chinese herbal compound ( Huo-Luo-Xiao-Ling Dan , HLXL ) effective treat OA knee addition participant current OA knee treatment ( ) also determine best dosage HLXL safe well tolerate .</brief_summary>
	<brief_title>Dose Escalation Study Of Chinese Herbs In Osteoarthritis Of The Knee</brief_title>
	<detailed_description>The specific aim project : 1 . To determine whether HLXL improve pain and/or function patient OA knee continue symptom despite receive standard analgesic and/or anti-inflammatory treatment , 2 . To identify optimal dosage HLXL , among three dosage , determine pain relief and/or functional improvement , dose-escalation , placebo-controlled double-blind randomize phase II clinical trial , conjunction indicia safety tolerability patient OA knee receive standard analgesic and/or anti-inflammatory treatment , 3 . To explore mechanisms action HLXL , correlate change biological marker suppression systemic inflammation change clinical response</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Age 40 year Diagnosis OA knee least 6 month duration fulfil American College Rheumatology criterion Pain least one knee least moderate severity ( Likert scale [ none , mild , moderate , severe , extreme ] VAS pain score least 40 [ 0100 ] ) ( least 15 ) day previous 1 month Taking analgesic nonsteroidal antiinflammatory agent control pain Documented radiographic change osteoarthritis knee ( KellgrenLawrence grade great equal 2 time screen ) Stable arthritis medication previous 1 month Willingness ability , help caregiver necessary , comply treatment followup procedure Use effective contraception woman childbearing potential Signed consent statement Intraarticular ( IA ) corticosteroid injection either knee within 3 month interval immediately prior baseline screen IA hyaluronates either knee within past 6 month Tidal lavage arthroscopy either knee within past 12 month Medical condition , judgment examiner and/or study investigator , may preclude safe participation protocol prevents completion study , : uncontrolled angina and/or congestive heart failure , severe chronic obstructive pulmonary disease , active treatment cancer , major psychiatric disease , severe systemic disease , significant abnormality screen physical examination laboratory test reveal clinically important abnormality hematological , cardiac , pulmonary , metabolic , renal , hepatic , gastrointestinal system Use constituent herb HLXL within past 3 month Current use Chinese herb arthritis Use oral prednisone past 30 day Current use anticoagulant ( coumadin , heparin , aspirin &gt; 325 mg per day ) . Use investigational drug within past 30 day Inflammatory arthritis ( e.g. , rheumatoid psoriatic arthritis ) Currently participate another intervention research study Unwilling randomize Plan move residence away immediate area within next 2 month Drug alcohol abuse sufficient hinder compliance treatment followup procedure Pregnant lactate Exclusive use wheel chair Surgery either knee past one year</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>OA</keyword>
</DOC>